Market OverviewThe Global RNA Therapeutics Market is valued at USD 13.3 Billion in 2023 and is projected to reach a value ...
Isomerase has strategically appointed three new associate directors to strengthen their leadership team as they continue to grow.  Dr Richard Reumerman, Dr Marin Sim and Dr Annabel Murphy will lead up ...
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename ...
At LogiMAT, one of the leading international trade fairs for intralogistics, KATHREIN Solutions will be presenting its new Generation 4 readers. These readers feature numerous innovations that enable ...
Students from two different faculties at Kingston University have teamed up to design and improve products in the pharmaceutical industry and help them meet consumer needs. As part of their final year ...
PharmiWeb.Jobs, the leading global life sciences job board, is pleased to share the latest episode of its new podcast, The PharmiWeb Podcast. The new episode 2025 Life Sciences Talent Strategy, ...
The Germany Continuous Positive Airway Pressure (CPAP) market is set for steady growth, with projections indicating a rise from USD 313.2 million in 2025 to USD 441.8 million by 2035, reflecting a 3.5 ...
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma ...
Care of Sweden is taking another step in its international journey by establishing a local operation in Spain. This new initiative is a strategic move to provide the market with direct access to ...
Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal α-amination of peptides and ...
Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment for the prevention of surgical site infections. The ...
Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2024 on Wednesday, March 19, 2025 at 7:00 am Eastern Daylight Time (EDT) / 11:00 am ...